Company: PTHS
Filing Date: 2025-05-09
Form Type: PREM14C
Source: 0001140361-25-018219
Chunk: 92

Company: Pelthos Therapeutics Inc.
Filing Date: 2025-05-09
Form: PREM14C
Chunk 92
---
 dramatically, and may decline rapidly, regardless of any developments in its business. Overall, there are various factors, many of which are beyond its control, that could negatively affect the market price of Channel common stock or result in fluctuations in the price or trading volume of Channel common stock, including:

| • | actual or anticipated variations in its annual or quarterly results of operations, including its earnings estimates and whether it meets market expectations with regard to its earnings; |

| • | its current inability to pay dividends or other distributions; |

| • | publication of research reports by analysts or others about Channel or the industry in which it operates, including the pharmaceutical or biotechnology industry which may be unfavorable, inaccurate, inconsistent or not disseminated on a regular basis; |

| • | changes in market valuations of similar companies; |

| • | market reaction to any additional equity, debt or other securities that it may issue in the future, and which may or may not dilute the holdings of its existing stockholders; |

| • | additions or departures of key personnel; |

| • | actions by institutional or significant stockholders; |

| • | short interest in Channel common stock or other securities and the market response to such short interest; |

| • | the dramatic increase in the number of individual holders of Channel common stock and their participation in social media platforms targeted at speculative investing; |

| • | speculation in the press or investment community about our company or industries in which Channel operates; |

| • | strategic actions by Channel or its competitors, such as acquisitions or other investments; |

| • | legislative, administrative, regulatory or other actions affecting its business, its industry, including positions taken by the FDA; |

| • | investigations, proceedings, or litigation that involve or affect it; |

| • | the occurrence of any of the other risk factors included in this information statement; and |

| • | general market and economic conditions. |

Channel common stock is currently listed on NYSE American. NYSE American may delist Channel common stock from trading, which could limit investors’ ability to make transactions in its securities and subject it to additional trading restrictions. Should Channel fail to satisfy the continued listing requirements for remaining listed on NYSE American, such as the corporate governance requirements or the minimum closing bid price requirement, NYSE American may take steps to delist Channel common stock. Such a delisting would likely have a negative effect on the price of Channel common stock and would impair your ability to sell or purchase Channel common stock when you wish to do so